Investor Relations - Reports and Publications
Here you find apoBank's reports and publications.
Interim Report 2023
apoBank increases operating result
Annual General Meeting 2023
Deutsche Apotheker- und Ärztebank (apoBank) pays its members a dividend of four percent for the 2022 financial year.
Two new board members
Heiko Drews and Dr. Christian Wiermann complete the apoBank Management Board.
Investor PresentationInvestor Presentation downloaden
Our financial calender 2023
|30 March||Publication results 2022 and annual financial report|
|30 March||Publication sustainability report (declaration of conformity to DNK (German version only))|
|19 April||Publication disclosure report 2022 (German version only)|
|28 April||Annual General Meeting 2023|
|26 May||Publication disclosure under Article 450 CRR and InstitutsVergV 2022 (German version only)|
|31 May||Publication disclosure report as of March, 2023 (German version only)|
|30 August||Publication interim report 2023|
|15 September||Publication disclosure report as of June 30, 2023 (German version only)|
|30 November||Publication disclosure report as of September 30, 2023 (German version only)|